92 related articles for article (PubMed ID: 22898820)
1. The transcription factor Wilms tumor 1 confers resistance in myeloid leukemia cells against the proapoptotic therapeutic agent TRAIL (tumor necrosis factor α-related apoptosis-inducing ligand) by regulating the antiapoptotic protein Bcl-xL.
Bansal H; Seifert T; Bachier C; Rao M; Tomlinson G; Iyer SP; Bansal S
J Biol Chem; 2012 Sep; 287(39):32875-80. PubMed ID: 22898820
[TBL] [Abstract][Full Text] [Related]
2. Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia.
Kuusanmäki H; Dufva O; Vähä-Koskela M; Leppä AM; Huuhtanen J; Vänttinen I; Nygren P; Klievink J; Bouhlal J; Pölönen P; Zhang Q; Adnan-Awad S; Mancebo-Pérez C; Saad J; Miettinen J; Javarappa KK; Aakko S; Ruokoranta T; Eldfors S; Heinäniemi M; Theilgaard-Mönch K; Wartiovaara-Kautto U; Keränen M; Porkka K; Konopleva M; Wennerberg K; Kontro M; Heckman CA; Mustjoki S
Blood; 2023 Mar; 141(13):1610-1625. PubMed ID: 36508699
[TBL] [Abstract][Full Text] [Related]
3. Curcumin attenuates Adriamycin-resistance of acute myeloid leukemia by inhibiting the lncRNA HOTAIR/miR-20a-5p/WT1 axis.
Liu JM; Li M; Luo W; Sun HB
Lab Invest; 2021 Oct; 101(10):1308-1317. PubMed ID: 34282279
[TBL] [Abstract][Full Text] [Related]
4. Pro-Inflammatory Activation Suppresses TRAIL-induced Apoptosis of Acute Myeloid Leukemia Cells.
Kobyakova MI; Senotov AS; Krasnov KS; Lomovskaya YV; Odinokova IV; Kolotova AA; Ermakov AM; Zvyagina AI; Fadeeva IS; Fetisova EI; Akatov VS; Fadeev RS
Biochemistry (Mosc); 2024 Mar; 89(3):431-440. PubMed ID: 38648763
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms underlying reversed TRAIL sensitivity in acquired bortezomib-resistant non-small cell lung cancer cells.
De Wilt L; Sobocki BK; Jansen G; Tabeian H; de Jong S; Peters GJ; Kruyt F
Cancer Drug Resist; 2024; 7():12. PubMed ID: 38835345
[No Abstract] [Full Text] [Related]
6. Co-targeting BCL-XL and BCL-2 by PROTAC 753B eliminates leukemia cells and enhances efficacy of chemotherapy by targeting senescent cells.
Jia Y; Han L; Ramage CL; Wang Z; Weng CC; Yang L; Colla S; Ma H; Zhang W; Andreeff M; Daver N; Jain N; Pemmaraju N; Bhalla K; Mustjoki S; Zhang P; Zheng G; Zhou D; Zhang Q; Konopleva M
Haematologica; 2023 Oct; 108(10):2626-2638. PubMed ID: 37078252
[TBL] [Abstract][Full Text] [Related]
7. Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulation.
Ho JNHG; Schmidt D; Lowinus T; Ryoo J; Dopfer EP; Gonzalo Núñez N; Costa-Pereira S; Toffalori C; Punta M; Fetsch V; Wertheimer T; Rittmann MC; Braun LM; Follo M; Briere C; Vinnakota JM; Langenbach M; Koppers F; Shoumariyeh K; Engel H; Rückert T; Märklin M; Holzmayer S; Illert AL; Magon F; Andrieux G; Duquesne S; Pfeifer D; Staniek J; Rizzi M; Miething C; Köhler N; Duyster J; Menssen HD; Boerries M; Buescher JM; Cabezas-Wallscheid N; Blazar BR; Apostolova P; Vago L; Pearce EL; Becher B; Zeiser R
Blood; 2022 Sep; 140(10):1167-1181. PubMed ID: 35853161
[TBL] [Abstract][Full Text] [Related]
8. Modulation of Bcl-x Alternative Splicing Induces Apoptosis of Human Hepatic Stellate Cells.
Wu L; Mao C; Ming X
Biomed Res Int; 2016; 2016():7478650. PubMed ID: 27579319
[TBL] [Abstract][Full Text] [Related]
9. An oral triple pill-based cocktail effectively controls acute myeloid leukemia with high translation.
Li M; Zheng S; Gong Q; Zhuang H; Wu Z; Wang P; Zhang X; Xu R
Biomed Pharmacother; 2023 Nov; 167():115584. PubMed ID: 37778270
[TBL] [Abstract][Full Text] [Related]
10. Emerging Therapies for Acute Myelogenus Leukemia Patients Targeting Apoptosis and Mitochondrial Metabolism.
Castelli G; Pelosi E; Testa U
Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30813354
[TBL] [Abstract][Full Text] [Related]
11. Studying Signaling Pathway Activation in TRAIL-Resistant Macrophage-Like Acute Myeloid Leukemia Cells.
Lomovskaya YV; Krasnov KS; Kobyakova MI; Kolotova AA; Ermakov AM; Senotov AS; Fadeeva IS; Fetisova EI; Lomovsky AI; Zvyagina AI; Akatov VS; Fadeev RS
Acta Naturae; 2024; 16(1):48-58. PubMed ID: 38698963
[TBL] [Abstract][Full Text] [Related]
12. WT1 β'ing catenin into shape: a new interaction driving epigenetic plasticity in acute myeloid leukemia?
Grey W
Haematologica; 2023 Jan; 108(1):5-6. PubMed ID: 35443569
[No Abstract] [Full Text] [Related]
13. Induction of Cell Death in the Human Acute Lymphoblastic Leukemia Cell Line Reh by Infection with Rotavirus Isolate Wt1-5.
Guerrero R; Guerrero C; Acosta O
Biomedicines; 2020 Jul; 8(8):. PubMed ID: 32722005
[TBL] [Abstract][Full Text] [Related]
14. Interferon-γ Promotes Antibody-mediated Fratricide of Acute Myeloid Leukemia Cells.
Fatehchand K; McMichael EL; Reader BF; Fang H; Santhanam R; Gautam S; Elavazhagan S; Mehta P; Buteyn NJ; Merchand-Reyes G; Vasu S; Mo X; Benson DM; Blachly JS; Carson WE; Byrd JC; Butchar JP; Tridandapani S
J Biol Chem; 2016 Dec; 291(49):25656-25666. PubMed ID: 27780867
[TBL] [Abstract][Full Text] [Related]
15. Truncated WT1 Protein Isoform Expression Is Increased in MCF-7 Cells with Long-Term Estrogen Depletion.
Santiago SA; Pablo ZB; Edgar MG; Karina CA; Mariela AR; Cristina RP
Int J Breast Cancer; 2021; 2021():6282514. PubMed ID: 34845427
[TBL] [Abstract][Full Text] [Related]
16. Transcript-Level Dysregulation of
Handschuh L; Wojciechowski P; Kazmierczak M; Lewandowski K
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34202143
[TBL] [Abstract][Full Text] [Related]
17. Activation of plasmacytoid dendritic cells promotes AML-cell fratricide.
Fatehchand K; Mehta P; Colvin CB; Buteyn NJ; Santhanam R; Merchand-Reyes G; Inshaar H; Shen B; Mo X; Mundy-Bosse B; Tridandapani S; Butchar JP
Oncotarget; 2021 Apr; 12(9):878-890. PubMed ID: 33953842
[TBL] [Abstract][Full Text] [Related]
18. WT1 Alternative Splicing: Role of Its Isoforms in Neuroblastoma.
Rasà DM; D'Amico AG; Maugeri G; Cavallaro S; D'Agata V
J Mol Neurosci; 2017 Jun; 62(2):131-141. PubMed ID: 28534317
[TBL] [Abstract][Full Text] [Related]
19. Distinct global binding patterns of the Wilms tumor gene 1 (WT1) -KTS and +KTS isoforms in leukemic cells.
Ullmark T; Järvstråt L; Sandén C; Montano G; Jernmark-Nilsson H; Lilljebjörn H; Lennartsson A; Fioretos T; Drott K; Vidovic K; Nilsson B; Gullberg U
Haematologica; 2017 Feb; 102(2):336-345. PubMed ID: 27612989
[TBL] [Abstract][Full Text] [Related]
20. Identification of a Novel C-Terminal Truncated WT1 Isoform with Antagonistic Effects against Major WT1 Isoforms.
Tatsumi N; Hojo N; Sakamoto H; Inaba R; Moriguchi N; Matsuno K; Fukuda M; Matsumura A; Hayashi S; Morimoto S; Nakata J; Fujiki F; Nishida S; Nakajima H; Tsuboi A; Oka Y; Hosen N; Sugiyama H; Oji Y
PLoS One; 2015; 10(6):e0130578. PubMed ID: 26090994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
